High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C

BACKGROUND: High prices of direct acting antivirals (DAAs) for hepatitis C virus (HCV) can lead to restrictions on access to treatment in high- and middle-income countries. An increasing number of people in these countries are treating their HCV infection with generic drugs produced in India, China,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Virus Erad
Autori principali: Hill, Andrew, Khwairakpam, Giten, Wang, James, Golovin, Sergey, Dragunova, Julia, Smith, Rachel, Houghton-Price, Vicky, Korologou-Linden, Roxanna, Nath, Sanjay, Savage, Anna, Jefferys, Greg
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mediscript Ltd 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632545/
https://ncbi.nlm.nih.gov/pubmed/29057082
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi